Jpmorgan Chase & CO Medpace Holdings, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MEDP
# of Institutions
636Shares Held
25.2MCall Options Held
38.7KPut Options Held
64.7K-
Black Rock Inc. New York, NY2.58MShares$820 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$804 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT967KShares$308 Million2.15% of portfolio
-
Invesco Ltd. Atlanta, GA807KShares$257 Million0.07% of portfolio
-
State Street Corp Boston, MA703KShares$223 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.89B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...